Therapeutically, upregulation of adipocyte enhancer-binding protein 1 (also upregulated in WM-266-4-derived exosomes) has also been shown to contribute to resistance to BRAF (V600E) inhibition in the treatment of melanoma [70]. Here, AEBP1 is linked to melanoma.